Digoxin Reduces Metastatic Risk
This is a news story, published by ScienceDaily, that relates primarily to CTC news.
biology news
For more biology news, you can click here:
more biology newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
metastases formation. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Breast cancer metastasis news, metastases news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
tumor cell cluster sizeScienceDaily
•Science
Science
Dissolving clusters of cancer cells to prevent metastases

73% Informative
Digoxin, a cardiac medication, dissolves clusters of circulating tumour cells in the blood, thus reducing the risk of metastases formation.
The active ingredient digoxin originally comes from the foxglove plant and can be prescribed for heart conditions such as heart failure.
Researchers hope to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.
VR Score
81
Informative language
88
Neutral language
23
Article tone
formal
Language
English
Language complexity
58
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links